Subscribe to RSS
Download PDF
DOI: 10.1055/a-2233-0245
Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway
Abstract
CircRNAs have been found to participate in the progression of various tumors. In the present study, we aimed to clarify the role of hsa_circ_0092355 in papillary thyroid cancer (PTC) cell development. RT-qPCR was used to determine the expression of hsa_circ_0092355, miR-543, and PDE5A. PTC cell proliferation was ascertained via a cell colony formation assay and the CCK-8 test. Western blotting was performed to examine the expression levels of PDE5A and apoptosis-associated proteins (Bcl-2 and Bax) in PTC cells. A scratch wound assay was performed to measure the migration of PTC cells. A mouse xenograft test was performed to assess the effects of hsa_circ_0092355 in vivo. RIP and dual-luciferase reporter assays confirmed the association between miR-543 and hsa_circ_0092355 or PDE5A. Associations between miR-543, hsa_circ_0092355, and PDE5A were evaluated using Pearson’s correlation coefficient. Upregulation of hsa_circ_0092355 was observed in PTC tissues. The hsa_circ_0092355 knockdown blocked the proliferation and migration of PTC cells and induced apoptosis. Moreover, hsa_circ_0092355 knockdown blocked PTC xenograft tumor growth in vivo. The miR-543 inhibitor could reverse the changes induced by hsa_circ_0092355 knockdown by hsa_circ_0092355 targeting miR-543. Furthermore, miR-543 suppresses PTC progression by downregulating PDE5A expression. Our findings suggest that the PTC tumor promoter hsa_circ_0092355 may promote carcinogenesis by controlling the miR-543/PDE5A pathway.
* Co-Corresponding authors
Publication History
Received: 26 June 2023
Accepted after revision: 05 December 2023
Article published online:
29 January 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart,
Germany
-
References
- 1 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249
- 2 Abdullah MI, Junit SM, Ng KL. et al. Papillary thyroid cancer: genetic alterations and molecular biomarker investigations. Int J Med Sci 2019; 16: 450-460
- 3 Cheng Q, Li X, Acharya CR. et al. A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors. Oncotarget 2017; 8: 16690-16703
- 4 Seib CD, Sosa JA. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin North Am 2019; 48: 23-35
- 5 Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol 2020; 21: 475-490
- 6 Patop IL, Kadener S. circRNAs in cancer. Curr Opin Genet Dev 2018; 48: 121-127
- 7 Yao Y, Chen X, Yang H. et al. Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis. J Exp Clin Cancer Res 2019; 38: 318
- 8 Zhang W, Liu T, Li T. et al. Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis. Cancer Gene Ther 2021; 28: 279-293
- 9 Huang C, Su X, Zhou DL. et al. A diagnostic and predictive lncRNA lnc-MPEG1-1 promotes the proliferation and metastasis of papillary thyroid cancer cells by occupying miR-766-5p. Mol Ther Nucleic Acids 2022; 28: 408-422
- 10 Wang D, Guo C, Kong T. et al. Serum miR-22 may be a biomarker for papillary thyroid cancer. Oncol Lett 2019; 17: 3355-3361
- 11 Chen L, Wang X, Ji C. et al. MiR-506-3p suppresses papillary thyroid cancer cells tumorigenesis by targeting YAP1. Pathol Res Pract 2020; 216: 153231
- 12 Qiu J, Zhang W, Zang C. et al. Identification of key genes and miRNAs markers of papillary thyroid cancer. Biol Res 2018; 51: 45
- 13 Yu Q, Zhang Z, He B. et al. MiR-543 functions as tumor suppressor in ovarian cancer by targeting TWIST1. J Biol Regul Homeost Agents 2020; 34: 101-110
- 14 Liu X, Gan L, Zhang J. miR-543 inhibites cervical cancer growth and metastasis by targeting TRPM7. Chem Biol Interact 2019; 302: 83-92
- 15 Yin S, Yang M, Li X. et al. Peripheral blood circulating microRNA-4636/-143 for the prognosis of cervical cancer. J Cell Biochem 2020; 121: 596-608
- 16 Lou W, Ding B, Wang J. et al. The involvement of the hsa_circ_0088494-miR-876-3p-CTNNB1/CCND1 axis in carcinogenesis and progression of papillary thyroid carcinoma. Front Cell Dev Biol 2020; 8: 605940
- 17 Yang Y, Ding L, Li Y. et al. Hsa_circ_0039411 promotes tumorigenesis and progression of papillary thyroid cancer by miR-1179/ABCA9 and miR-1205/MTA1 signaling pathways. J Cell Physiol 2020; 235: 1321-1329
- 18 Li Z, Xu J, Guan H. et al. Circ_0059354 aggravates the progression of papillary thyroid carcinoma by elevating ARFGEF1 through sponging miR-766-3p. J Endocrinol Invest 2022; 45: 825-836
- 19 Panda AC. Circular RNAs act as miRNA sponges. Adv Exp Med Biol 2018; 1087: 67-79
- 20 Pan Y, Xu T, Liu Y. et al. Upregulated circular RNA circ_0025033 promotes papillary thyroid cancer cell proliferation and invasion via sponging miR-1231 and miR-1304. Biochem Biophys Res Commun 2019; 510: 334-338
- 21 Qi Y, He J, Zhang Y. et al. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4. Oncol Rep 2021; 45: 50
- 22 Li R, Hou S, Zou M. et al. miR-543 impairs cell proliferation, migration, and invasion in breast cancer by suppressing VCAN. Biochem Biophys Res Commun 2021; 570: 191-198
- 23 Wang D, Cai L, Tian X. et al. MiR-543 promotes tumorigenesis and angiogenesis in non-small cell lung cancer via modulating metastasis associated protein 1. Mol Med 2020; 26: 44
- 24 Zhai F, Cao C, Zhang L. et al. miR-543 promotes colorectal cancer proliferation and metastasis by targeting KLF4. Oncotarget 2017; 8: 59246-59256
- 25 Takimoto E, Champion HC, Belardi D. et al. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism. Circ Res 2005; 96: 100-109
- 26 Sponziello M, Verrienti A, Rosignolo F. et al. PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells. Endocrine 2015; 50: 434-441
- 27 Lee HY, Li CC, Li WM. et al. Identification of potential genes in upper tract urothelial carcinoma using next-generation sequencing with bioinformatics and in vitro analyses. PeerJ 2021; 9: e11343
- 28 Arozarena I, Sanchez-Laorden B, Packer L. et al. Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A. Cancer Cell 2011; 19: 45-57
- 29 Nagel S, Schneider B, Rosenwald A. et al. t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2. Genes Chromosomes Cancer 2011; 50: 996-1009